Results 251 to 260 of about 2,579,690 (304)

Extracellular vesicles derived from edible plants and edible fungi: Compositional characteristics, engineering strategies and biofunctions

open access: yesFood Biomacromolecules, EarlyView.
Non‐animal extracellular vesicles as bioactive‐compound carriers: compositional characteristics, engineering strategies, and biofunctions. Abstract Animal‐derived extracellular vesicles (EVs) were widely used for bioactive compound delivery but constrained by complex origins, potential immunogenicity, and pathogen contamination.
Jiahao Yu   +6 more
wiley   +1 more source

GLUT1 expression, lymphocyte distribution and CD3<sup>+</sup> T-cell metabolic subsets as predictive markers of response to immunotherapy in advanced melanoma. [PDF]

open access: yesJ Exp Clin Cancer Res
Paver EC   +12 more
europepmc   +1 more source

A Computed Tomography Radiomics Approach for Assessing the T Cell‐Inflamed Gene Expression Profile in Hepatocellular Carcinoma and Its Association With Immunotherapy Response

open access: yesHealth Care Science, EarlyView.
The T cell‐inflamed gene expression profile (GEP) provides a biomarker for immunotherapy response across various cancers. We established a CT‐based radiomics model to predict the T cell‐inflamed GEP and immunotherapy response in hepatocellular carcinoma (HCC).
Mimi Tang   +11 more
wiley   +1 more source

Craniofacial Resection for Advanced Cutaneous Squamous Cell Carcinoma: Results From the 2nd International Collaborative Case‐Series

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Robust outcome data for anterior skull base cutaneous squamous cell carcinoma (cSCC) are limited, particularly as emerging therapies reshape management. We evaluated survival and prognostic factors following craniofacial resection. Methods Retrospective multi‐institutional case‐series (1995–2015) of patients who underwent skull base
Michael J. C. Schachtel   +52 more
wiley   +1 more source

Delineation and monitoring of the T cell repertoire of adoptive cell transfer product during the treatment of advanced melanoma. [PDF]

open access: yesGenome Med
Kerr C   +12 more
europepmc   +1 more source

Antibiotic Exposure Does Not Impact Anti-BRAF/Anti-MEK Targeted Therapy Outcome in Patients with Advanced Melanoma. [PDF]

open access: yesCurr Oncol
Wang YS   +12 more
europepmc   +1 more source

Prognostic Biomarkers for Anti-PD-1 Monoclonal Antibodies in the First Line Treatment of Advanced Melanoma. [PDF]

open access: yesInt J Dermatol
Pásek M   +6 more
europepmc   +1 more source

Response rate and long-term survival in patients with advanced melanoma: data from the prospective cohort study gem-1801. [PDF]

open access: yesClin Transl Oncol
Espinosa E   +32 more
europepmc   +1 more source

Late-Onset Immune-Related Adverse Events in Patients with Advanced Melanoma: The LATENT Study. [PDF]

open access: yesCancers (Basel)
Pozas J   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy